Abstract
Dipeptidyl peptidase IV (DPPIV) is a 110-kD, trans-membrane, ectoenzyme, with ubiquitous expression. DPPIV has numerous functions including involvement in T-cell activation, cell adhesion, digestion of proline containing peptides in the kidney and intestines, HIV infection and apoptosis, and regulation of tumorigenicity in certain melanoma cells. Constitutively expressed on numerous epithelial cell types, DPPIV is often disregulated in a variety of human malignancies. The most striking evidence of DPPIV down-regulation is found in transformed melanocytes, where nearly 100% of melanomas lack DPPIV expression. We have identified DPPIV as a gene that can alter the invasive potential of a number of melanoma cell lines. By transfecting the full-length cDNA of DPPIV, we have established stable melanoma cell lines that express comparable levels of the DPPIV protein as normal epidermal melanocytes. Matrigel invasion assays were utilized to study the effects of DPPIV expression on the invasive potential of these cells. The parental and vector transfectants readily migrated across the Matrigel while the invasiveness of DPPIV transfected cells was reduced by greater than 75%. The effects on cellular invasion are not attributed to overall growth characteristics, as both DPPIV expressing and non-expressing cells behave comparably in culture. We have also constructed mutants of DPPIV that lack either the extra-cellular serine protease activity or the six amino acid cytoplasmic domain. Both mutants were stably expressed in melanoma cells. Matrigel invasion assays performed with cells expressing the two mutant forms of the protein revealed phenotypic effects similar to wild type function. In this study, we have demonstrated that expression of a proteolytically active form of the DPPIV protein inhibits the invasiveness of malignant melanoma cell lines lacking endogenous DPPIV expression. Furthermore, we have shown that neither the protease activity nor the cytoplasmic domain of DPPIV is required for its anti-invasive activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lee JH et al. KiSS-1, a novel human malignant melanoma metastasissuppressor gene. J Natl Cancer Inst 1996; 88: 1731–7.
Steeg PS et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200–4.
Ten Kate J et al. Adenosine deaminase complexing protein in cancer studies. Anticancer Res 1986; 6: 983–8.
Houghton AN et al. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J Exp Med 1988; 167: 197–212.
Fox DA et al. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 1984; 133: 1250–6.
Fleischer B. A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J Immunol 1987; 138: 1346–50.
Cheng HC et al. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 1998; 273: 24207–15.
Johnson RC et al. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J Cell Biol 1993; 121: 1423–32.
Gaetaniello L et al. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. Hepatology 1998; 27: 934–42.
Morimoto C et al. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc Natl Acad Sci USA 1994; 91: 9960–4.
Jacotot E et al. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Virology 1996; 223: 318–30.
Hegen M, Camerini D, and Fleischer B. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell Immunol 1993; 146: 249–60.
Nishihara H et al. Multiple forms of human adenosine deaminase. II. Isolation and properties of a conversion factor from human lung. Biochem Biophys Acta 1973; 302: 429–42.
Tanaka T et al. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 1995; 64: 326–31.
ten Kate J et al. Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas. Cancer Res 1984; 44: 4688–92.
Morrison ME et al. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 1993; 177: 1135–43.
Wesley UV et al. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 1999; 190: 311–22.
Miki T et al. An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene 1989; 83: 137–46.
Chien J et al. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells. Oncogene 1999; 18: 3376–82.
Janulis M et al. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. J Biol Chem 1999; 274: 801–13.
Albini A et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239–45.
Repesh LA. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989; 9: 192–208.
Hendrix MJ et al. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 1987; 38: 137–47.
Welch DR et al. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 1991; 47: 227–37.
Welch DR et al. Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents. Int J Cancer 1989; 43: 449–57.
Nagatsu T et al. New chromogenic substrates for X-prolyl dipeptidylaminopeptidase. Anal Biochem 1976; 74: 466–76.
Pineiro-Sanchez ML et al. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 1997; 272: 7595–601.
Lee JH, Welch DR. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 1997; 57: 2384–7.
Li L et al. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst 1989; 81: 1406–12.
Dong JT et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995; 268: 884–6.
Gao AC et al. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997; 57: 846–9.
Tanaka T et al. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 1993; 90: 4586–90.
Aoyama A, Chen WT. A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci USA 1990; 87: 8296–300.
Monsky WL et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994; 54: 5702–10.
Yaron A, Naider F. Proline-dependent structural and biological properties of peptides and proteins. [Review] [383 refs]. Crit Rev Biochem Mole Biol 1993; 28: 31–81.
Rettig WJ et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res 1993; 53: 3327–35.
Fodstad O et al. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer 1988; 41: 442–9.
Miki T et al. Development of a highly efficient expression cDNA cloning system: Application to oncogene isolation. Proc Natl Acad Sci USA 1991; 88: 5167–71.
Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd ed., Vol 3. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pethiyagoda, C., Welch, D. & Fleming, T. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis 18, 391–400 (2000). https://doi.org/10.1023/A:1010930918055
Issue Date:
DOI: https://doi.org/10.1023/A:1010930918055